Heart Attack Diagnostics Market to Reach around USD 15.4 Billion by 2024| Key participants Siemens Healthcare GmbH

The Report Heart Attack Diagnostics Market Analysis by Test type (Electrocardiogram, Blood Tests (Troponin, CK-MB), Echocardiogram), by Region (U.S., Canada, UK, Germany, China, India, Brazil, Mexico, South Africa, Middle East), and Segment Forecasts to 2024

The heart attack diagnostics market is expected to reach USD 15.4 billion by 2024, according to a new report by Grand View Research, Inc. The heart attack diagnostics market is anticipated to witness a lucrative growth during the forecast period from2016 to 2024. From 2001 to 2011, age-standardized, heart attack incidence rates have significantly decreased worldwide. However, the overall risk factors and the disease burden remains large, thereby rendering the heart attack diagnostic sectors a profitable growth prospect. This growth is attributed to a majority of factors, such as high prevalence of coronary heart diseases, increased tobacco smoking, and obesity, enhanced adoption of unhealthy diet is resulting in a high cholesterol incidence in individuals, particularly in the rising geriatric population. However, the low Medicare reimbursement provided for the mobile cardiac outpatient telemetry electrocardiogram (ECG) and the progressively declining heart attack incidence rates are expected to hamper the market growth. 

The heart attack diagnostics market has been classified by product into electrocardiogram, which measures the electrical activity of the heart; echocardiogram, a form of ultrasound test that provides images of the heart; blood tests that measure the expression of certain proteins in excess, such as troponin levels, and cardiac enzymes; and other diagnostic products. The ECG segment is expected to witness a significant growth rate in developing countries, owing to the technological advances coupled with increasing applications of ECG. Although, the increasing demand for cost effective, rapid blood tests such as troponin and Creatine Kinase MB Isoenzyme (CK-MB) is likely to acquire major market share in the near future. The key countries landscape included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and Middle East. The Asia Pacific region is anticipated to be the fastest growing region during the forecast period. On the other hand, North America is estimated to dominate the global heart attack diagnostics market.  

Access Research Report of Heart Attack Diagnostics Market @ www.grandviewresearch.com/industry-analysis/heart-attack-diagnostics-market

Further key findings from the study suggest:

• North America is estimated to dominate the global heart attack diagnostics market. The increasing awareness about heart attacks, its causative and risk factors, and enhanced uptake and acceptance of technologically advanced diagnostics is expected to contribute to the market growth.
• The Asia Pacific region is expected to be the fastest growing region during the forecast period. to The reason being the considerably large burden of heart diseases in certain developing regions, such as in India, where 2.4 million people die annually due to heart diseases. As a result of the soaring incidences of heart diseases, an urgent requirement to undertake awareness measures and incorporate advanced diagnostics is expected to fuel the market growth.
• The troponin blood test type is the largest grossing segment and is expected to capture the largest share in 2015, especially in developing countries including Brazil, China, and India. Its applications as a cardiac monitoring device and its indispensable use as a heart attack diagnostic tool will be a contributing factor supporting the market growth. The industry comprises of several local as well as global players. Some of the major players of this industry include Siemens Healthcare GmbH, Schiller AG, GE Healthcare, and Hitachi Medical Systems. 

Grand View Research has segmented the heart attack diagnostics market on the basis of product and region: 

Heart Attack Diagnostics Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• Electrocardiogram (ECG)
• Blood tests
• Others

Heart Attack Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Durable Medical Equipment Market Expected to Witness a CAGR of 6.1% through 2026

The Report Durable Medical Equipment (DME) Market Size, Share & Trends Analysis Report By Product, By End Use (Hospitals, Nursing Homes), By Region (North America, MEA, APAC, Europe), And Segment Forecasts, 2019 - 2026

The global durable medical equipment (DME) market size is expected to reach USD 271.0 billion by 2026 registering a CAGR of 6.1%, according to a new report by Grand View Research, Inc. The market is primarily driven by rise in chronic diseases, such as kidney failures and cancer. Moreover, technological advancements along with strong reimbursement scenario will boost the DME market further. For instance, in January 2019, WHILL, Inc., a U.S.-based personal electric vehicle, introduced new technology WHILL autonomous drive at the Consumer Electronic Sow held at the Las Vegas. In the past, Medicare has taken steps to bring reimbursement of DME products in line with other payers.

In this direction, in December 2015, the Center for Medicare & Medicare Services (CMS) issued a new rule of prior authorization process for DME, Prosthetics, Orthotics, and Supplies (DMEPOS). The DMEPOS includes the master list of 135 items, which require prior authorization before beneficiary receives an item. In addition, growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and lack of skilled professionals may limit the durable medical equipment market growth.

Access Research Report of Durable Medical Equipment Market @ https://www.grandviewresearch.com/industry-analysis/durable-medical-equipment-dme-market

Further key findings from the study suggest:

• Personal mobility devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability
• Nursing homes is anticipated to be the fastest-growing segment over the study period as these facilities offer custodial care like skilled care, such as bathing and dressing
• Europe led the market with the largest share in 2018 and will witness a steady growth in future on account of the presence of major companies in the region
• Asia Pacific is expected to register the highest CAGR from 2019 to 2026 owing to the presence of a large target population base and improving healthcare facilities
• Some of the key companies in the global DME market are Invacare Corporation; ArjoHuntleigh; Stryker Corporation; Hill Rom, Inc.; Drive Medical; GF Health Products, Inc.; Sunrise Medical; Medline Industries, Inc.; and Carex Health Brands, Inc.

Grand View Research has segmented the global Durable Medical Equipment (DME) market on the basis of product, end use, and region:

DME Product Outlook (Revenue, USD Million, 2015 - 2026)

• Personal Mobility Devices
• Bathroom Safety Devices and Medical Furniture
• Monitoring and Therapeutic Devices

DME End Use Outlook (Revenue, USD Million, 2015 - 2026)

• Hospital
• Nursing Homes
• Home Healthcare
• Other

DME Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Arthroscopy Market To Make Great Impact In Near Future by 2024

Global arthroscopy market is anticipated to reach USD 6.34 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population base and rising obesity levels are the major factors driving the growth.

Rising medical tourism, cost efficiency and faster recovery rate are some of the factors resulting in increased adoption. As a result, demand for arthroscopy is increasing, since it’s used in the diagnosis of joint conditions. In addition, constant decline in the price coupled with reimbursement coverage is spurring the adoption of arthroscopy in the treatment of injuries.

Presently, the sector is fragmented in nature with presence of many players competing with each other. The key players are implementing mergers and acquisition strategies to strengthen their position by the expansion of customer base and reduce the number of competing players.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/arthroscopy-market

Further key findings from the study suggest:

• Arthroscopic implant segment dominated globally and is estimated to remain dominant throughout the forecast period. Increasing adoption of implants for diagnosis is mainly driving the growth of the segment.
• The arthroscopic visualization systems are anticipated to witness strong demand during the forecast period due to their ability to provide clear high definition resolution of internal organs.
• The demand for Fluid Management Systems is going to increase considerably during the forecast period with new products entering the sector especially in emerging countries such as Brazil, Mexico and South Africa.
• The key players have faced challenges due to severe pricing pressures and stringent regulatory guidelines. The existing companies are finding it difficult to garner strong revenues.
• Rising demand for minimally surgeries is also supporting the revenue growth since arthroscopy supports the same.
• China, India, Brazil and South Africa are anticipated to register significant growth over the forecast period owing to rising patient awareness related to arthroscopy, presence of largest pool of geriatric population prone to injuries and the surging prevalence of chronic diseases such as osteoarthritis, bone tumor and rheumatoid arthritis.
• Lenient regulatory approval procedures in Asia Pacific are offering easy entry of the new products in the region.
• Some of the key players operating at the global level include but are not limited to ConMed Corporation, Arthrex Inc, Stryker Corporation, Olympus Corporation, Smith & Nephew plc, DePuy Synthes and Zimmer Biomet.
• North America dominated the global scenario with regional share of over 40.0% in 2015. Technological advancements, such as introduction of advanced visualization systems, primarily led to highest revenue generation in the region. Visualization systems help in minimally invasive surgery by providing 3D image of the joint.
• In addition, favorable reimbursement structure, presence of large target patient population and well defined regulatory framework are few factors that are positively affecting the market.

Grand View Research has segmented the Arthroscopy market on the basis of product, application, and region:

Arthroscopy Market, by Product

• Powered Shave Systems
• Visualization Systems
• Fluid Management Systems
• Ablation Systems
• Arthroscopes
• Arthroscope Implants
• Accessories and Disposables

Arthroscopy Market, by Application

• Hip
• Knee
• Shoulder
• Foot & Ankle
• Hand & Wrist
• Elbow
• Sports Medicines

Arthroscopy Market, by Region

• North America
  • US.Arthroscopy Market, by Product
  • US.Arthroscopy Market, by Application
  • Canada Arthroscopy Market, by Product
  • Arthroscopy Market, by Application
• Europe
  • Germany Arthroscopy Market, by Product
  • UK.Arthroscopy Market, by Product
• Asia Pacific
  • China Arthroscopy Market, by Product
  • Japan Arthroscopy Market, by Product
• Latin America
  • Brazil Arthroscopy Market, By Product
  • Mexico Arthroscopy Market, By Product
  • Rest of Latin America Arthroscopy Market, By Product
• MEA
  • South Africa Arthroscopy Market, By Product
  • Middle East Arthroscopy Market, By Product

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Aesthetic Lasers Market is Estimated To Expand at a CAGR of 15.5% through 2024

The Report Aesthetic Lasers Market Analysis by Application (IPL Laser Treatment, Laser Skin Resurfacing, Noninvasive Tightening, Laser-Assisted Lipoplasty, Laser Hair Removal), and Segment Forecasts to 2024

The global aesthetic lasers market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. The demand is expected to upsurge due to aging population, high prevalence of obesity, and wide range of safe and effective treatments. Moreover, growing awareness about the safety and efficacy of lasers coupled with its ease of use is also expected to propel its cosmetic applications.

Advancement of technology has made needle-free procedures possible, thus boosting the rate of adoption of laser treatments. Young population also opts for cosmetic procedures as preventive measures for and to slow down the aging process.

Companies operating in this market are making huge investments in research and development of new products and holding patents. For instance, in 2014, Cutera (provider of energy-based medical Aesthetic technologies) invested USD 10.5 million for pure research purposes and holds 34 patents along with5 patent applications in the pipeline.

Stringent regulations for the cosmetic laser products are projected to ensure increasing efficiency of the devices while treating the skin without any adverse effects. The manufacturers of laser devices have to comply with the Federal Food, Drug, and Cosmetic Act in addition to radiation safety performance standards defined by the Federal Regulations.

In April 2016, Oculus Innovative Sciences, Inc. received the FDA approval for Microcyn-based Lasercyn Gel, intended for post-non-ablative laser therapy procedures management

Access Research Report of Aesthetic Lasers Market @ http://www.grandviewresearch.com/industry-analysis/aesthetic-lasers-market

Further Key Findings from the Study Suggests:

• Hair removal is the fourth most common minimally invasive procedure across the globe with approximately 1 million procedures done in the year 2011.It dominated the application segment in terms of number of procedures owing to the changing beliefs of beauty and lifestyle.
• Conventional hair removal methods are painful and temporary. Thus, using lasers for permanent hair removal proves to be efficient. Also, growing safety assurance results in more people opting for it. Almost 97% people who have undergone the procedure report satisfactory outcomes.
• Laser skin resurfacing segment is expected to grow at a rapid rate over the forecast period. This is attributed to the fact that it reduces the signs of aging and improves skin texture, tone, & laxity. Furthermore, increasing innovation and technological advancements brought in by the market players are expected to propel demand of the segment in the coming years.
• For instance, Sciton JOULE is an expandable platform that offers an unprecedented laser array and light wavelengths via any of its three distinct delivery modes that are broadband light, fiber, and arm, enabling practitioners with the maximum versatility to perform surgical and Aesthetic procedures from a single platform. It is the first OptiPlex platform to accommodate abovementioned three distinct delivery modes.
• Some incredible creative solutions have been prompted with the increasing demand for laser skin resurfacing. In 2010, Solta Medical (fractional resurfacing and noninvasive skin tightening pioneer) announced an FDA clearance of Fraxel restore Dual for treating actinic keratosis.
• North America dominated the market in 2015. It is due to the early acceptance of laser technology and growing awareness about lasers and its efficiency in treating all the skin type.
• The prevalence of medical spas is very high in this region. In 2012, approximately 2,100 med spas were operative in the U.S., generating revenue USD 1.94 billion per year. This number grew to USD 3.6 billion in 2016. Growing emphasis on beauty and attractiveness and its direct impact on success are expected to further increase the market share of the region.
• Some key players are Solta Medical, Inc. (acquired by Valeant Pharmaceuticals); Lumenis; Cynosure, Inc.; STRATA Skin Sciences; Syneron Medical Ltd., Lutronic, Cutera, Viora, Lynton Lasers, and Sciton, Inc.
• The industry is experiencing many mergers and acquisitions between competitors. In December 2014, Valeant Pharmaceuticals International acquired Solta Medical, Inc. in USD 236 million.
• In 2015, Mela Sciences acquired XTRAC and VTRAC laser and lamp systems from PhotoMedex, Inc. in USD 42.5 million. Moreover, the company was renamed to Strata Skin Sciences.

Grand View Research has segmented the global aesthetic lasers market on the basis of application and regions:

Aesthetic Lasers Application Outlook (Revenue, USD Million, 2013 - 2024)

• IPL Laser Treatment
• Laser Skin Resurfacing
• Noninvasive Tightening
• Laser-Assisted Lipoplasty
• Laser Hair Removal

Aesthetic Lasers Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Therapeutic Drug Monitoring Market Poised to Expand at a Robust Pace Over 2024

The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/therapeutic-drug-monitoring-market

Further key findings from the study suggest:

• The consumables segment covered over 65% of the market share in 2015 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
• The immunoassay segment held the largest market share in 2015. The presence of several commercially available immunoassays combined with their associated benefits including the cost effectiveness and easy-to-handle nature of the products are the key drivers for the growth of this segment.
• The proteomics category is expected to be the fastest growing technology segment due to the advent of various proteomic technologies, such as isotope-coded affinity tags, next generation sequencing, and protein microarray platforms that enable rapid mining of the proteome.
• The hospital is the largest end-use segment with a share of over 60% in 2015. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
• The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.
• In 2015, North America was the highest revenue generating region with revenue generated over USD 900 million. The rising number of R&D activities coupled with the high awareness about personalized therapy is the major determining factor for the large share captured by the North America region.
• Few of the leading market players are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and Alere, Inc. The persistent R&D efforts are being undertaken along with numerous other strategic endeavors being adopted by the market players with the objective of enhancing the present drug monitoring practices and to develop novel technologies.

Grand View Research has segmented the therapeutic drug monitoring market on the basis of product, technology, application, end-use, and region:

Therapeutic Drug Monitoring Market, Product Outlook, by Revenue (USD Million, 2013 - 2024)

• Consumables
• Equipment
• Others

Therapeutic Drug Monitoring Market, Technology Outlook, by Revenue (USD Million, 2013 - 2024)

• Immunoassays
• Proteomic technologies
• Others

Therapeutic Drug Monitoring Market Drug, Class Outlook, by Revenue (USD Million, 2013 - 2024)

• Anti-epileptics
• Antibiotics
• Immunosuppressants
• Psychoactive drugs
• Antiarrhythmic drugs
• Others

Therapeutic Drug Monitoring Market, End-use Outlook, by Revenue (USD Million, 2013 - 2024)

• Hospital labs
• Private labs
• Others

Therapeutic Drug Monitoring Market, Regional Outlook, by Revenue (USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibiotics Market Strong Application and Emerging Trends also Scope by 2026| Top Industry Leaders Sanofi, Novartis AG, Bayer AG

The global antibiotics market size is expected to reach USD 62.06 billion by 2026 expanding at a CAGR of 4.0%, according to a new report by Grand View Research, Inc. Rising prevalence of infectious diseases, especially in developing regions like Asia Pacific and Middle East, is anticipated to contribute to the market growth. More than 15.0% of the deaths in children below the age of five years, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the disease is highly prevalent in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one-third of the infected population, thereby increasing the disease burden.

Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the forecast period. This is further expected to facilitate development of advanced drugs. According to an article published by the Pew Charitable Trusts, nearly 30% of the outpatient oral antibiotics prescriptions are unnecessary and majority of these are prescribed for disease conditions, such as non-bacterial infections and acute respiratory conditions, against which antibiotics are not significantly effective. Such indiscriminate use of antibiotics is anticipated to increase the risk of difficult-to-treat antibiotic-resistant infections, thereby increasing the economic burden.

Access Research Report of Antibiotics Market@ https://www.grandviewresearch.com/industry-analysis/antibiotic-market

Further key findings from the study suggest:

• RNA and folic acid synthesis inhibitors are anticipated to witness healthy CAGRs over the forecast period
• Development of several antiviral drugs, which inhibit transcription and reverse transcription process are anticipated to support this growth
• Asia Pacific is anticipated to witness the highest CAGR over the forecast period on account of large population base, prevalence of infectious diseases, regulation reforms, and wide usage of generic medicine
• Latin America, especially Brazil, is also projected to exhibit remunerative growth due to strong growth in pharmaceutical sector
• Outbreak of certain viruses, such as Ebola, in African region contributed to the region’s growth
• Some of the key companies in the market are Pfizer, Inc; Janssen Pharmaceuticals; Abbott laboratories; GlaxoSmithKline plc; Sanofi S.A.; Novartis AG; Bayer AG; Bristol Myers Squibb Company; Eli Lilly & Company, and Astellas Pharma, Inc.

Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:

Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2015 - 2026)

• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors

Antibiotics Drug Class Outlook (Revenue, USD Million, 2015 - 2026)

• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolides
• Carbapenems
• Aminoglycosides
• Sulfonamide
• Other

Antibiotics Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Geriatric Medicine Market to Register Stable Expansion by – 2024|Top Industry Players Sanofi S.A., Bristol-Myers Squibb

The global geriatric medicine market is expected to reach over USD 1,017 billion by 2024 according to a new report by Grand View Research Inc. Increase in the global geriatric population is one of the major challenges for the healthcare industry and the governments across the globe, however, it has proven to be a boon for the geriatric medicine market. 

The high market growth is anticipated on account of the rising prevalence of various target diseases in the geriatric population, the demographic shift, the upward trend in lifestyle-related risk factors, and the significantly improved access to affordable healthcare as well as medicine across the developing and emerging economies. 

The rising prevalence of the Alzheimer’s disease in the geriatric population is expected to serve as a high impact rendering driver for the geriatric medicine market over the forecast period. In 2015, as per the estimates published by the Alzheimer’s disease International, nearly 47 million people have dementia and this number is expected to double after every 20 years. Furthermore, as per the estimates published by The Alzheimer's Association, in the U.S., out of the 5.4 million Americans living with the disease, nearly 5.2 million or 96.3% are aged 65 and above.

In order to mitigate the concerns arising due to the unfavorable shift in the demographic variables such as age, lifestyle patterns, economic development, coupled with the upward shift in the disease trends associated with the geriatric population, the developed regions have consistently improved their healthcare practices by allocating high amount of resources towards the healthcare and social development sectors.

For instance, the U.S., Germany, the UK, and Japan allocate 17.1%, 11.30%,9.10%,10.20%, of their GDP respectively towards healthcare expenditure and majority of these resources are channelized towards developing new drugs, new software, and building technology platforms for hospitals and home health services.

Access Research Report of Geriatric Medicine Market@ www.grandviewresearch.com/industry-analysis/geriatric-medicine-market

Further key findings from the study suggest:

• In 2015, analgesic medicine accounted for the highest revenue of nearly USD123 billion. The key factors attributed to include the rising prevalence of various types of pains associated with aging. These pains can be categorized as general body pain, post-surgical pain, muscle pain, acute or chronic joint pain, neuropathic pain, and others.
• In 2015, North America dominated the geriatric medicine market with a revenue share of over 37% owing to the presence of well-developed social and healthcare sectors, the availability of the latest medicine, and insurance coverage coupled with the presence of a large number of people aged above 60 years.
• Asia Pacific region is anticipated to exhibit the maximum growth rate at a CAGR of over 7% from the year 2016 to 2024. In comparison with the developed regions, the economic burden of the target diseases, the access to healthcare, health insurance and the percentage of public and private healthcare expenditures vary significantly in the Asia Pacific countries.
• The countries such as China and India are expected to witness a significant rise in the elderly population base and this factor in turn is expected to create an upward trend in the geriatric medicine market over the forecast period.
• The market dynamics indicate the presence of strong competition amongst the key players such as Eli Lilly and Company, AstraZeneca plc, Boehringer Ingelheim GmbH, Abbott Laboratories., Sanofi S.A., Bristol-Myers Squibb, Merck & Company Inc., Novartis AG, Pfizer, Inc., and GlaxoSmithKline Plc.

Grand View Research has segmented the geriatric medicine market by therapeutic category, therapeutic condition, and region:

Geriatric Medicine Market by therapeutic category (USD Billion, 2016 - 2024)

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotics
• Antidepressants

Geriatric Medicine Market by therapeutic condition, by Revenue (USD Billion,2016 - 2024)

• Cardiovascular diseases
• Arthritis
• Neurological Disorders
• Cancer
• Osteoporosis
• Respiratory

Geriatric Medicine Market Regional Outlook, by Revenue (USD Billion, 2016 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Alopecia Market Set to Surge Significantly During the Forecast Period

The global alopecia market size is poised to reach USD 5.3 billion by 2027 and is anticipated to register a CAGR of 9.5% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of diseases across the globe, technological progress, and growth in per-capita expenditures toward healthcare are some of the factors expected to drive the market growth in the coming years.

There has been a marked increase in the overall disease prevalence due to changing lifestyle patterns such as surging consumption of tobacco and alcohol, unhealthy and inconsistent food habits, intense stress levels, and expanding geriatric population, thus contributing to the market growth. In addition, rising incidences of chronic diseases such as rheumatoid arthritis, cancer, and Polycystic Ovary Syndrome (PCOS) are anticipated to fuel the market growth.

The National Alopecia Areata Foundation stated that 147 million people are suffering from alopecia areata worldwide. Expanding consumer awareness towards this disease and possible treatments options are expected to augment the alopecia market growth. For instance, National Alopecia Areata Foundation’s Treatment Development Program (TDP) has accelerated the research work pertaining to this condition.

Rogaine and Propecia remain the only FDA-approved products in this market. Patent expiration of branded drugs has expanded the generic penetration in this space. However, impending launch of multiple promising pipeline products, such as Xeljanz (tofacitinib), Jakafi (ruxolitinib), Breezula (clascoterone), SM04554, and Lumigan (Bimatoprost) is likely to inflate market growth in the near future.

Reimbursement for alopecia treatment continues to be a major challenge in this market. Most treatment modalities for this disorder are considered cosmetic and not medically essential, thus mostly remain uncovered under insurance schemes. Frequent doctor visits, coinsurance for procedures, and prescription drug copays are some of the major out-of-pocket costs for this disease treatment.

Access Research Report of Alopecia Market @ http://www.grandviewresearch.com/industry-analysis/alopecia-market

Further key findings from the study suggest:

• The alopecia areata disease type segment contributed for over 30% of the revenue share in 2019
• The androgenetic alopecia disease type segment is positioned to demonstrate a growth rate of over 10% over the forecast period
• The homecare settings end-use segment is projected to be broadening penetration of laser treatment and rise in regulatory sanctions of home-use products
• Asia Pacific is anticipated to witness the fastest growth owing to large population base and rising consumer awareness toward available treatment options
• Economic betterment and increased per capita healthcare spending, in developing countries such as India, China, and Singapore are expected to boost the regional market
• Lack of stringent reimbursement policies is a major factor restraining the market growth since the treatment for this disorder is not considered medically essential
• Some of the key companies in the market of the key companies in the market are Johnson and Johnson Services, Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Lexington International LLC; Merck & Co., Inc.; Cirrus Hair Centers; and Transitions Hair Pty Ltd.

Grand View Research has segmented the global alopecia market on the basis of disease type, end use, sales channel, gender, and region:

Alopecia Disease Type Outlook (Revenue, USD Million, 2015 - 2027)

• Alopecia Areata
• Cicatricial Alopecia
• Traction Alopecia
• Alopecia Totalis
• Alopecia Universalis
• Androgenetic Alopecia
• Others

Alopecia End-use Outlook (Revenue, USD Million, 2015 - 2027)

• Homecare Setting
• Dermatology Clinics

Alopecia Sales Channel Outlook (Revenue, USD Million, 2015 - 2027)

• Prescriptions
• OTC

Alopecia Gender Outlook (Revenue, USD Million, 2015 - 2027)

• Male
• Female

Alopecia Regional Outlook (Revenue, USD Million, 2015 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Sweden
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Taiwan
  • Vietnam
  • Thailand
  • Malaysia
  • Singapore
  • Indonesia
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt
  • Iran
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hemodynamic Monitoring Devices Market To Make Great Impact In Near Future by 2024| Key Industry Participants Hemo Sapiens, Inc

The global hemodynamic monitoring devices market is expected to reach USD 1.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for non-invasive monitoring techniques coupled with the rising prevalence of chronic illness is expected to drive the market over the forecast period. 

The hemodynamic monitoring market is influenced by new technologies such as echocardiography, thoracic electrical bio-impedance and others that maybe used to non-invasively monitor parameters such as cardiac output, arterial pressure, blood oxygen level, and central venous pressure. 

Furthermore, the rising population of critically ill patients coupled with defective healthcare facilities with drawbacks, such as understaffing, is propelling market players to develop minimal invasive hemodynamic monitoring devices that may be used in clinical and home care settings. Along with the new product development, the market is also anticipated to witness the development of technologies that help in the early diagnosis of shock and sepsis. 

Furthermore, efforts by key industry players to understand critical illnesses at molecular levels leading to the development of efficient assessment products are expected to be witnessed over the forecast period. Hence, all these company strategies and the research conducted are eventually expected to promote market growth over the forecast period.

Access Research Report of Hemodynamic Monitoring Devices Market @ www.grandviewresearch.com/industry-analysis/hemodynamic-monitoring-devices-market

Further key findings from the study suggest:

• The disposables segment is anticipated to be the largest segment by 2024. The rising sale of hemodynamic monitoring systems and increasing applications of these systems in home care settings, hospitals, and clinics are expected to boost the segment growth.
• The non-invasive devices segment is expected to be the fastest growing hemodynamic monitoring market. Risks that include the development of arrhythmias due to the use of pulmonary artery catheter and the development of other methodologies that measure the cardiac output, such as echocardiographs, are the vital impact rendering drivers.
• Asia Pacific is anticipated to be the fastest growing regions and is anticipated to contribute to about 20.0% of the global revenue by 2024. The strengthening of the distribution channels by companies and the registration of products in countries, such as China, India, Australia, and others, are expected to support the growth over the forecast period. For instance, LiDCO Group, in their 2016 prelim report emphasized on its strategy of appointing new distributors for the Australian and South East Asian region.
• Major industry players are Edward Lifesciences, LiDCO Group Plc, Deltex Medical, Philips Medical, GE Healthcare, Noninvasive Medical Technologies, Inc., Tensys Medical, Inc., Cardio-Dynamics International, and Drager Medical, Inc. As mentioned above, the new product development is expected to drive the market over the forecast period.
• For instance, in March 2016, the LiDCO Group received the U.S. FDA approval for the LiDCO unity and launched the product in the European region. Along the same time, LiDCO also succeeded in registering itself in China to explore untapped territories and increase their global presence.

Grand View Research has segmented the Hemodynamic Monitoring Devices Market on the basis of product, type, end-use and regions. 

Global Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2014 - 2024)

• Monitoring systems
• Disposables
• Services

Global Hemodynamic Monitoring Devices Type Outlook (Revenue, USD Million, 2014 - 2024)

• Invasive Hemodynamic Monitoring System
• Minimally Invasive Hemodynamic Monitoring System
• Non-invasive Hemodynamic Monitoring System

Global Hemodynamic Monitoring Devices End-use Outlook (Revenue, USD Million, 2014 - 2024)

• Hospitals
• Catheterization Laboratories
• Others

Hemodynamic Monitoring Devices Market Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Internet of Things in Healthcare Market is Growing at Significant Rate 2025

The global IoT in healthcare market size is projected to reach USD 534.3 billion by 2025 expanding at a CAGR 19.9% over the forecast period, according to a new report by Grand View Research, Inc. Rise in investments for the implementation of IoT solutions in healthcare sector is one of the key factors driving the market. Increasing penetration of connected devices in various healthcare institutes and adoption of IoT systems and software solutions in healthcare operational activities are also among the key factors augmenting the market growth.

Growing preference for real-time data monitoring among the healthcare practitioners to manage chronic diseases is expected to propel the demand for IoT network in healthcare institutions. Combinations of remote monitoring, mobile platforms, and analytics have cut the rate of readmissions of patients suffering from congestive heart failure, diabetes, and blood pressure. Furthermore, advancements in communication technologies, such as real-time data transmission, has positively impacted the patients in manage chronic diseases and medication dosage, which has further fostered the market growth.

For instance, connected wheelchairs allow people with disabilities to communicate health alerts to care teams and engage with care providers. Growing number of IoT platform installations for better and early diagnosis and disease tracking is also contributing to the market development. Furthermore, rising demand for digital technologies for managing diseases, such as insomnia, diabetes, autism, heart disease, and asthma, is also poised to spur the market growth.

Access Research Report of Internet of Things in Healthcare Market@ https://www.grandviewresearch.com/industry-analysis/internet-of-things-iot-healthcare-market

Further key findings from the study suggest:

• In 2018, services held the largest revenue share owing to the high demand for improved decision-making in real-time and uninterrupted data flow between devices and people to uplift the efficiency of medical systems
• Hospitals and clinics held the largest revenue share in 2018 due to increased investments by hospitals to encourage the usage of digital technologies
• North America is expected to be the largest market owing to growing adoption of healthcare IT solutions and availability of sophisticated infrastructure in the region
• Asia pacific expected to witness the fastest CAGR over the forecast period owing to growing investments by the pharmaceuticals & medical devices companies and increasing adoption of advanced technologies
• Key companies operating in this market include Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Biotronik, and Boston Scientific

Grand View Research has segmented the global IoT in healthcare market on the basis of component, connectivity technology, end use, application, and region:

IoT in Healthcare Component Outlook (Revenue, USD Million, 2014 - 2025)

• Medical Devices
  • Wearable External Devices
  • Implanted Medical Devices
  • Stationary Medical Devices
• System and Software
  • Remote Device Management
  • Network Bandwidth Management
  • Data Analytics
  • Application Security
  • Network Security
• Services
  • System Integration Services
  • Consulting, Training, and Education
  • Support and Maintenance Services

IoT in Healthcare Connectivity Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Wi-Fi
• Bluetooth Low Energy
• ZigBee
• Near Field Communication (NFC)
• Cellular
• Satellite

IoT in Healthcare End Use Outlook (Revenue, USD Million, 2014 - 2025)

• Clinical Research Organizations
• Hospitals and Clinics
• Research and Diagnostic Laboratories
• Others

IoT in Healthcare Application Outlook (Revenue, USD Million, 2014 - 2025)

• Telemedicine
• Medication Management
• Clinical Operations
• Inpatient Monitoring
• Connected Imaging
• Others

IoT in Healthcare Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Surface Marker Detection Market is Expected To Register A Significant Growth Over The Forecast Period

The Report Cell Surface Marker Detection Market Analysis By Product (Flow Cytometry, Hematology Analyzers, Reagents & Kits), By Application (Disease Diagnosis & Identification, Research & Drug Discovery) And Segment Forecasts To 2022

The global cell surface marker detection market is expected to reach USD 6.49 billion by 2022, according to a new report by Grand View Research, Inc. This growth in demand can be attributed to rise in incidence of oncology diseases and other cell-associated disorders. 

Rapid introduction of advancements and automations in clinical laboratories is a key factor affecting this industry. Incorporation of novel algorithms pertaining to diagnosis and prognosis of chronic disorders is expected to fuel demand of this market in the coming years.

Requirement of solutions for data handling and interpretation of clinical conditions based on obtained results are anticipated to enhance potential for R&D in this sector, consequently driving market growth over the forecast period. 

Access Research Report of Cell Surface Marker Detection Market @ https://www.grandviewresearch.com/industry-analysis/cell-surface-marker-detection-market

Further key findings from the report suggest:

• Flow cytometry devices accounted for over 70% of the revenue generated in the industry for 2014. This large share can be attributed to the growing advancement in these instruments such as enhancement in efficiency and resolution of fluorescence-based cytometric detectors. Furthermore, presence of large product portfolio of different industry players operating in cytometry is responsible for large market share of this technique. 
• Disease diagnosis and identification accounted for over 50% of the revenue generated in the market for 2014. High incidence rate of cell-associated disorders and oncology diseases that need to be treated in order to curb the mortality rate are the major drivers for growth of this segment. 
• Determination of novel drug targets and development of biopharmaceuticals for prognosis of chronic diseases is anticipated to propel growth of research and drug discovery sub-segment in the coming years. With expected development of this segment, the sector will witness lucrative growth over the forecast period. 
• North America accounted for the largest share of this sector for 2014, as there are is significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for biopharmaceuticals is also anticipated to fuel regional growth. 
• North America dominated the industry in 2014, with revenue estimated at USD 999.0 million. Presence of sophisticated healthcare infrastructure and favorable government initiatives with respect to analytical techniques and their applications for disease diagnosis and drug development are some key factors likely to drive growth. 
• Asia Pacific is expected to witness lucrative growth from 2015 to 2022 due to the presence of high-unmet medical needs coupled with rapidly rising healthcare R&D investment and growing medical expenditures in emerging economies of India and China 
• Key participants of the cell surface marker detection industry include Siemens Healthcare, Nihon Kohden Corporation, Sartorius, Janssen Diagnostics Inc., Grifols SA, Thermo Fisher Scientific, BioRad Laboratories Inc., and F. Hoffman La Roche Ltd. 
• These participants are involved in R&D for production of cell-specific antibodies and collaborations with smaller entities operating in the market as well as with academic research laboratories in order to maintain their market position and enter the untapped market regions 

Grand View Research has segmented cell surface marker detection market on the basis of product, application, and region:

Cell Surface Marker Detection Product Outlook (Market Revenue in USD Million, 2012 - 2022)

• Flow Cytometry
• Hematology Analyzers
• Reagents & Kits

Cell Surface Marker Detection Application Outlook (Market Revenue in USD Million, 2012 - 2022)

• Disease Diagnosis & Identification
• Research & Drug Discovery
• Others

Cell Surface Marker Detection Regional Outlook (Market Revenue in USD Million, 2012 - 2022)

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neuroscience Market will be worth USD 30.80 Billion by 2020

Global neuroscience industry demand was worth USD 24.09 Billion in 2013 and is anticipated to reach above USD 30.80 billion by 2020. Rising investment in R&D resulting in the development of numerous products in the neuroinformatics coupled with adequate funding from the government are key factors that drive growth in this market.

Neuro-informatics involve designing and developing efficient tools and algorithms that can augment the performance of structural and functional mapping. Global Neuroscience market is expected to grow at CAGR of 2.9% over the next seven years.

Increasing occurrence of malicious disorders including Parkinsonism and Alzheimer’s disease together with other inherited CNS disorders has resulted in increased necessity for new improvements in neuroscience industry. The market is expected to experience growth over the forecast period on account of growing demand in laboratories and academic centers. The market players aim at introducing unique technologies with the ability to obtain insights to understand better the compound nervous functionalities and neural manipulations. Furthermore, increasing aggregate geriatric population every year is anticipated to drive significantly the demand owing to a growing need for better treatment and medication.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/neuroscience-market

Rising demand for imaging machines & microscopic devices and intraneural imaging tools for visualization of intra-neural links is also foreseen to serve as a growth driver for this industry over the forecast period. In 2013, electrophysiology technology, whole brain imaging and neuro-microscopy equipment intended for neuroscience research collectively formed the chief revenue producing units owing to rapid advancements in these techniques that allow brain imaging with single cell resolution PET, MRI, and other advanced microscopes are expected to witness substantial growth due to expected developments in near future.

Neuro-cellular manipulation and neuro-proteomic analysis are estimated to record fastest growth rate of over 3.5% owing to improvements regarding disease etiology over the forecast period. Instrumentation of technology modules for Neuroscience market accounted for the largest share of the market in terms of revenue as a result of highly priced instruments used in neuro-analytical testing. Also, data analysis and software implements are predicted to observe a significant growth in the next seven years on account of efficient data tracking algorithms and methodologies.

In 2013, North America emerged as the largest regional market contributing to over 40.0% of the overall revenue owing to extensive ongoing research projects assisted by government universities. Furthermore, the surge in the incidence of CNS-related disorders in the regional population is expected to propel growth in the next seven years.

The Asia Pacific industry for neuroscience is estimated to grow at a CAGR of nearly 3.0% over the forecast period to reach a revenue over USD 8.00 billion by 2020. The increase in patient awareness coupled with the presence of unmet medical needs on nervous system syndromes is expected to drive market growth. In addition to increasing healthcare expenses in emerging markets of China and India are anticipated to propel growth in demand.

Key companies include Sutter Instrument Corporation, Trifoil Imaging Inc., Newport Corporation, Femtonics Ltd., Neurotar Ltd., Scientifica Ltd, Intan Technologies, AxionBiosystemsNeuralynxInc, Blackrock Microsystems LLC, Thomas Recording GmbH, LaVisionBiotec GmbH, PlexonInc, Mediso Medical Imaging Systems, NeuroNexus Technologies and Alpha Omega.

The market is characterized by intense competition on account of growing number of firms and extensive R&D. Companies in the market emphasize on new developments using advanced technology to differentiate and trace neural mechanisms.

Grand View Research has segmented neuroscience market on the basis of technology, technology components, and region:

Neuroscience Technology Outlook (Revenue, USD Million, 2012 - 2020)

• Whole Brain Imaging
  • Structural imaging
  • Functional imaging
• Neuro-microscopy Electrophysiology
  • Fluorescence neuromicroscopy
    • Confocal
    • Two-photon
    • Epifluorescent
    • TIRF
  • Electron neuromicroscopy
    • Scanning electron
    • Electron tomography
    • Transmission electron
  • Light neuromicroscopy
• Neuro-functional Analysis
• Neuro-proteomic analysis
• Neuro-cellular manipulation
• Neuro-biochemical assays
• Stereotaxic surgeries
  • Neural activity implants
  • Long-term access implants
  • Neurochemistry
• Animal behavior
  • Non-human primates
  • Rodent related
  • Optogenetics actuators
  • Optogenetics sensors
  • Drosophila related
  • elegansrelated

Neuroscience Technology Component Outlook (Revenue, USD Million, 2012 - 2020)

• Instrumentation
• Data analysis and services
• Consumables

Neuroscience Regional Outlook (Revenue in USD Million, 2012 - 2020 )

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ECG Equipment Market to Mark a Highest CAGR of 5.9% Through 2022| Top Industry Leaders Schiller AG, Nihon Kohden

The global ECG equipment market is expected to reach USD 6.3 billion by 2022, according to a new report by Grand View Research Inc. The rising incidences of cardiovascular disorders and government initiatives to make people aware about health check-ups are expected to boost market growth. In addition, the change in the medical preference from acute intervention to preventive care is expected to increase the demand for more accurate and cost-effective methods for heart monitoring.

According to the WHO, in 2012, around 17.5 million people died due to cardiovascular diseases. This is due to the late diagnosis and absence of early symptoms as the patient fails to keep record of his vital signs.

Owing to the increasing incidences, government is undertaking various awareness programs. According to the American Heart Association (AHA), 56% women identified heart disease as a leading cause of death in 2012 as compared to 30% in 1997.

Access Research Report of ECG Equipment Market@ www.grandviewresearch.com/industry-analysis/ecg-equipment-market

Further key findings from the report suggest:

• ECG monitoring equipment has high future growth potential owing to changing trend towards preventive care and new product innovation with data integration. In February 2014, Medtronic launched its FDA approved Reveal LINQ. The upgraded version of Reveal XT offers patient heart monitoring for three years with 20% more data memory than its previous version.
• ECG stress testing systems is one of the dominating segments of the market. The growing need for flexible stress systems and comprehensive data management is driving the market for this segment. Quinton 9500 series from Cardiac Science portable system allows physicians to optimize the examination space and enables more data integrations.
• Holter monitoring systems is another segment, which is expected to gain significant market share over the forecast period due to the fact that the system assists in identifying arrhythmias that takes place during certain activities such as exercise, stress, bowel movements, sleep, eating, and stress
• 2M Engineering Ltd. launched the VitaMove 2S ExG movement and ECG-recorder, which is equipped with 3-lead ECG holter, that combines daily activities with heart rate events/trends, ECG, and derivatives such as Heart Rate Variability (HRV)
• North America dominated the market in 2014 and is expected to grow at a CAGR of 5.8% over the forecast period. With major industry players situated in North America, the innovations and upgrading rates are higher as compared to other regions. In August 2015, InfoBionic along with Safeguard Scientists raised USD 8 million to commercialize Mome Kardia. Mome Kardia is a remote patient monitoring system based on the cloud technology that could be worn around the neck.
• Asia Pacific is expected to witness substantial growth during the forecast period owing to the rising incidence rate of heart diseases and growing manufacturing outsourcing in the region
• According to the Government of India, the prevalence of heart failure in the nation due to hypertension, obesity, coronary heart disease, obesity, rheumatic heart disease, diabetes ranges from 1.3 to 4.6 million and an annual incidence rate of 491,600 to 1.8 million
• As per a report published by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), people have adopted unhealthy lifestyles along with increasing stress levels, decreasing physical activity, tobacco smoking, and increasing consumption of saturated fats
• Industry players are constantly fueling the market with newer technologies or upgrading existing technology. In May 2015, CardioComm Solutions, Inc. launched HeartCheck PEN. This Bluetooth wireless connectivity pen could be connected for data acquisition with Android and Apple smartphones.
• Apart from technology innovations, many industry players are expanding their global presence by signing distribution agreements with domestic distributors. In October 2015, iNeedMD Holdings, Inc. signed a distribution agreement with Clifton Africa Ltd. This one-year distribution agreement is worth USD 1.5 million.
• Key players of the ECG equipment market include Medtronic, GE Healthcare, Philips Healthcare, Schiller AG, Nihon Kohden, CardioComm Solutions, Inc., and Johnson & Johnson.

Grand View Research has segmented the global ECG equipments market on the basis of product type and region:

ECG equipment type outlook (Revenue, USD Million, 2012 - 2022)

• ECG Monitoring Equipment
• Holter Monitoring Systems
• Event Monitoring Systems
• ECG Stress Testing Systems

ECG equipment regional outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• RoW
  • Australia
  • Brazil

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Banking Outsourcing Market Expected To Propel Industry Growth By 2022

The global cell banking outsourcing market is expected to reach USD 9.87 billion by 2022, according to a new report by Grand View Research, Inc. Factors attributing towards this anticipated market size include growing demand for gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites.

Additionally, rise in prevalence of oncology associated diseases and other infectious chronic disorders are expected to promote cytological R&D in which cell banking plays a pivotal role thereby driving growth. R&D for commercialization of novel characterization and cryopreservation methods is also expected to considerably enhance lucrative growth opportunities over the forecast period.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/cell-banking-outsourcing-market

Further key findings from the report suggest:

• Master cell banks accounted for over 60% of revenue generated in 2014 owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for stem cell therapy and gene therapy thereby resulting to segment growth.
• Stem cells accounted for the largest share with respect to revenue in cell banking market by cell type. Factors attributive towards large share of this segment include availability of stem cells from different organ origins and there consequent use in different metabolic disorders.
• North America accounted for the largest share of this market for 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for vaccines and biopharmaceuticals is also anticipated to fuel the growth of this region.
• Asia Pacific is expected to witness significant growth in demand over the forecast period owing to increase in number of supportive government initiatives pertaining to investments in biotechnology sector. Additionally, ongoing R&D activities for cancer treatment and fertility preservation facilitate the demand for cell banking services.
• Key participants in the cell banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., and CordLife.
• Market participants are involved in R&D for characterization of cell banks which include introduction of efficient gene sequencing tests, karyology, and safety tests.

Grand View Research has segmented cell banking outsourcing market on the basis of bank type, cell type, phase of development of cell bank, and region:

Cell Banking Outsourcing Outlook, by Bank Type (Revenue, USD Million, 2012 - 2022 )

• Master Cell Banking
• Working Cell Banking
• Viral Cell Banking

Cell Banking Outsourcing Outlook, by Cell Type (Revenue, USD Million, 2012 - 2022 )

• Stem Cell Banking
  • Cord Stem Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-stem Cell Banking

Cell Banking Outsourcing Phase Outlook (Revenue, USD Million, 2012 - 2022 )

• Cell Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Bank Characterization and Testing
  • Safety Testing
    • Viral Cell Bank Safety Testing
    • Microbial Cell Bank Safety Testing
    • Gene Expression Testing
    • Karyology Testing
    • Gene Sequencing Testing
  • Cell Bank Preparation
    • Master Cell Bank Preparation
    • Working Cell Bank Preparation

Cell Banking Outsourcing Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK
• Asia Pacific
  • Japan
  • China
  • India
  • Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Blood Pressure Monitoring Device Market Expected to Succeed in CAGR of 10.1% by 2026

The global blood pressure (BP) monitoring devices market size is expected to reach USD 2.47 billion by 2026, according to a new report by Grand View Research, Inc. exhibiting a CAGR of 10.1% during the forecast period. The growing global geriatric population base is expected to widen the consumer base by triggering incidence rates of hypertension, which is expected to drive the demand for blood pressure monitoring devices. Increasing incidence of hypertension has led to rising demand for cost-effective, rapid and accurate diagnostic solutions. Blood pressure monitors are one of the vital sign monitors of life. The cost-effective and accurate results offer by these indicators is the factor responsible for the market growth.

In addition, new product launches coupled with rising adoption of technologically advanced products due to high penetration of health insurance is considered as another factor fueling the demand for BP monitoring devices. The increasing popularity of mHealth platform in the healthcare sector is additionally, propelling the market growth. Rising patient awareness levels about advantages associated with portable monitoring devices are expected to positively reinforce market growth.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-pressure-monitoring-devices-market

Further Key Findings From the Report Suggest:

• Sphygmomanometer/ aneroid BP monitors dominated the overall market in 2018 in terms of revenue share, owing to the increasing prevalence of high blood pressure worldwide.
• Ambulatory blood pressure monitoring device market is driven by factors such as increasing adoption by clinicians and awareness about it.
• Digital BP monitors segment is expected to witness lucrative growth in the coming years owing to advantages associated with these devices such as ease of use, immediate results, and low cost. In addition, continuous improvement in these devices is expected to present this market with further growth opportunities.
• Home healthcare segment is expected to witness lucrative growth owing to the government initiatives to promote home healthcare.
• In 2018, North America was the key regional market in terms of revenue share. Key factors attributing to its large share include the presence of advanced healthcare infrastructure and increasing prevalence of lifestyle-associated diseases with a high risk of hypertension.
• Higher awareness levels, increasing demand for early diagnostics & prevention and increasing stress levels leading towards high blood pressure are the factors responsible for the market growth.
• Asia Pacific blood pressure monitoring device market is expected to demonstrate rapid growth during the forecast period with CAGR of 12.2% key factors attributing to its rapid growth include favorable government initiatives such as the government of India's campaign "Make In India" which is intended to attract FDI and international players to invest in Indian market. In addition, rapidly improving healthcare facilities are anticipated to market growth.
• The key players operating in the market include Omron Healthcare, GE Healthcare, A&D Medical Inc., Welch Allyn Inc., SunTech Medical, Inc., Withings, Briggs Healthcare, Microlife AG, Kaz Inc., Philips Healthcare, American Diagnostics Corporation, Rossmax International Ltd., Spacelabs Healthcare Inc., and GF Health Products Inc.

Grand View Research has segmented the global blood pressure monitoring device market on the basis of product, end-use, and region:

Blood Pressure Monitoring Device Product Outlook (Revenue, USD Million; 2014 - 2026)

• Sphygmomanometer/Aneroid BP Monitor
• Automated/Digital Blood Pressure Monitor
  • Arm
  • Wrist
  • Finger
• Ambulatory Blood Pressure Monitor
• Transducers
  • Disposable
  • Reusable
• Instruments and Accessories
  • Blood pressure cuffs
    • Disposable
    • Reusable
  • Others

Blood Pressure Monitoring Devices End-Use Outlook (Revenue, USD Million; 2014 - 2026)

• Hospitals
• Ambulatory Surgical Centers & Clinics
• Home Healthcare

Blood Pressure Monitoring Devices Regional Outlook (Revenue, USD Million; 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.